- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 213/55 - AcidesEsters
Détention brevets de la classe C07D 213/55
Brevets de cette classe: 303
Historique des publications depuis 10 ans
|
24
|
17
|
17
|
16
|
21
|
17
|
23
|
18
|
19
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Sutro Biopharma, Inc. | 174 |
8 |
| H. Lundbeck A/S | 1261 |
8 |
| Saudi Arabian Oil Company | 13708 |
7 |
| The Scripps Research Institute | 1351 |
7 |
| Chugai Seiyaku Kabushiki Kaisha | 1388 |
6 |
| Bristol-myers Squibb Company | 4793 |
5 |
| Syngenta Crop Protection AG | 6292 |
5 |
| Sumitomo Chemical Company, Limited | 9106 |
5 |
| F. Hoffmann-La Roche AG | 7895 |
4 |
| Gilead Sciences, Inc. | 2112 |
4 |
| University of Kansas | 891 |
4 |
| The Wistar Institute of Anatomy and Biology | 463 |
4 |
| Merck Sharp & Dohme LLC | 3737 |
4 |
| The Regents of the University of California | 20315 |
3 |
| Janssen Pharmaceutica N.V. | 3345 |
3 |
| Allergan, Inc. | 2310 |
3 |
| FUJIFILM Corporation | 29911 |
3 |
| The Board of Trustees of the University of Illinois | 2727 |
3 |
| Abide Therapeutics, Inc. | 26 |
3 |
| AC Immune S.A. | 272 |
3 |
| Autres propriétaires | 211 |